His primary areas of investigation include Internal medicine, Surgery, Pathology, Cancer and Pancreatic disease. His Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Oncology. His work on Laparotomy, Angiography and Resection is typically connected to Decay curve as part of general Surgery study, connecting several disciplines of science.
His study in Pathology is interdisciplinary in nature, drawing from both Surgical oncology, Angiogenesis and Metastasis. His studies deal with areas such as Pharmacokinetics, Cancer research, Clinical trial and Dose–response relationship as well as Cancer. His work deals with themes such as Zollinger-Ellison syndrome, Endoscopic ultrasound and Insulinoma, which intersect with Pancreatic disease.
H. Richard Alexander focuses on Internal medicine, Surgery, Cancer, Pathology and Cancer research. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology. H. Richard Alexander focuses mostly in the field of Surgery, narrowing it down to matters related to Zollinger-Ellison syndrome and, in some cases, Pancreatic disease.
The study incorporates disciplines such as Malignancy, Peritoneal mesothelioma and Clinical trial in addition to Cancer. His Pathology research is multidisciplinary, incorporating perspectives in Endothelial stem cell, Metastasis and Isolation perfusion. The various areas that H. Richard Alexander examines in his Cancer research study include Tumor necrosis factor alpha, Immunology, Genetic enhancement and Pancreatic cancer.
H. Richard Alexander spends much of his time researching Internal medicine, Cancer, Peritoneal surface, Oncology and Pancreaticoduodenectomy. In his research on the topic of Internal medicine, Biliary fistula is strongly related with Gastroenterology. His work on Adenocarcinoma as part of general Cancer research is often related to In patient, thus linking different fields of science.
His Peritoneal surface research includes elements of Appendiceal neoplasms, Intensive care medicine, General surgery and Pathology. To a larger extent, H. Richard Alexander studies Surgery with the aim of understanding Pancreaticoduodenectomy. As part of one scientific family, H. Richard Alexander deals mainly with the area of Surgery, narrowing it down to issues related to the Intraperitoneal chemotherapy, and often Surgical oncology.
Peritoneal surface, Internal medicine, Peritoneal mesothelioma, Oncology and Mesothelioma are his primary areas of study. His research in Peritoneal surface intersects with topics in Appendiceal neoplasms, Radiology and Pathology. In his study, he carries out multidisciplinary Internal medicine and Gastrinoma research.
His biological study spans a wide range of topics, including Malignancy, Chemotherapy, Abdominal cavity, Survival rate and Pemetrexed. H. Richard Alexander combines subjects such as Cancer stem cell and Cancer research with his study of Mesothelioma. His study in Cancer research is interdisciplinary in nature, drawing from both Signal transduction and Peritoneum.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia.
Pasha Sarraf;Robert C. Frederich;Ewa M. Turner;Grace Ma.
Journal of Experimental Medicine (1997)
Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.
Steven K. Libutti;Giulio F. Paciotti;Adriana A. Byrnes;H. Richard Alexander;H. Richard Alexander.
Clinical Cancer Research (2010)
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
Anne M Lewis;Sheelu Varghese;Hui Xu;H Richard Alexander.
Journal of Translational Medicine (2006)
Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
J. Andrea McCart;Jerrold M. Ward;John Lee;Yun Hu.
Cancer Research (2001)
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy
Andrew L. Feldman;Steven K. Libutti;James F. Pingpank;David L. Bartlett.
Journal of Clinical Oncology (2003)
The role of interleukin 1 in growth and metastasis of human cancer xenografts.
Dina M Elaraj;David M Weinreich;Sheelu Varghese;Markus Puhlmann.
Clinical Cancer Research (2006)
Prospective Molecular Profiling of Melanoma Metastases Suggests Classifiers of Immune Responsiveness
Ena Wang;Lance D. Miller;Galen A. Ohnmacht;Simone Mocellin.
Cancer Research (2002)
Radiofrequency Ablation of Adrenal Tumors and Adrenocortical Carcinoma Metastases
Bradford J. Wood;Jame Abraham;Jame Abraham;L R N Julia Hvizda;H. Richard Alexander.
A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma.
Nora Jaskowiak;Nora Jaskowiak;Jeffrey A. Norton;H. Richard Alexander;John L. Doppman.
Annals of Surgery (1996)
Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).
Joseph A. Blansfield;Lynda Choyke;Shane Y. Morita;Peter L. Choyke.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: